Skip to content

Lumibird Launches OMNICAD for Ocular Surface Disease Diagnostics

๐Ÿ†• ๐‹๐ฎ๐ฆ๐ข๐›๐ข๐ซ๐ ๐‹๐š๐ฎ๐ง๐œ๐ก๐ž๐ฌ ๐Ž๐Œ๐๐ˆ๐‚๐€๐ƒ ๐Ÿ๐จ๐ซ ๐Ž๐œ๐ฎ๐ฅ๐š๐ซ ๐’๐ฎ๐ซ๐Ÿ๐š๐œ๐ž ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ญ๐ข๐œ๐ฌ ๐Ÿ‘€

๐Ÿ‘ Lumibird Medical - Quantel Medical, Ellex & Optotek has introduced the OMNICAD, an advanced imaging platform developed by its subsidiary, Quantel Medical, for diagnosing ocular surface disease (OSD). Marketed as the "most complete automatic premium imaging platform," OMNICAD features exclusive meibography, high-quality imaging, and AI-powered algorithms.

๐Ÿ‘จโ€โš•๏ธ Designed for ease of use, it includes a large screen and full connectivity options like DICOM, USB, WiFi, and more. Currently, the OMNICAD is available exclusively in the U.S., offering clinicians a cutting-edge tool for OSD diagnosis.